The group�s principal activity is tp provide drug development and contract manufacturing serving to the pharmaceutical and biotechnology industries. The group was founded in early 1990�s. The group�s service includes formulation evaluation, analytical services, clinical manufacturing, biotechnology services, regulatory support, formulation development and commercial manufacturing. The group operates from the United States.
